Archive for October, 2004

Big pharma's pain could be biotech's gain

Big pharma’s pain could be biotech’s gain “Current problems besetting ‘big pharma’ could have a silver lining for the smaller biotechnology sector, some investors believe.”


Click here for reuse options!
Copyright 2004 Biotechblog

Big pharma’s pain could be biotech’s gain

Big pharma’s pain could be biotech’s gain “Current problems besetting ‘big pharma’ could have a silver lining for the smaller biotechnology sector, some investors believe.”


Click here for reuse options!
Copyright 2004 Biotechblog

Few Americans Buy Meds Online

Few Americans Buy Meds Online “Few American adults have bought prescription drugs through the internet, despite rising drug costs and increased pressure to import cheaper drugs from abroad, according to a new study released Sunday. “


Click here for reuse options!
Copyright 2004 Biotechblog

The Waning Of The Blockbuster Drug

The Waning Of The Blockbuster Drug “What’s promising now are drugs that target niche diseases. That means painful restructuring ahead for Big Pharma “


Click here for reuse options!
Copyright 2004 Biotechblog

Beleaguered Merck looks to future

Beleaguered Merck looks to future “A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the market and losing a quarter of its stock market value as a result, Merck & Co. will try to dodge the storm clouds and turn its attention tomorrow to a brighter subject with the official […]


Click here for reuse options!
Copyright 2004 Biotechblog

%d bloggers like this: